Immune-based biomarkers for measurement of tumor microenviornment (TME)
Why Tumor Mutational Burden (TMB)?
Aspects of immune cell activity and their pro and anti-tumor characteristics
End-to-end Laboratory Testing for Infectious Diseases and Vaccine Development
Signatures characterizing key immune cell subtypes, pathways, and individual genes
Q&A with Mark Edinger
NGS influenza typing assay for vaccine and therapeutic development
Technical feasibility for utilizing TruSightTumor 170 NGS assay (+UMIs) to analyze ctDNA
LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods
Next generation sequencing-based big data solutions
Clinical trials today involve sophisticated sample collection and analysis. Samples are tested to...
The client’s primary objective was to establish a central environment for the life-cycle...